BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22221894)

  • 21. Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras
    Kumar G; Madka V; Singh A; Farooqui M; Stratton N; Lightfoot S; Mohammed A; Rao CV
    Neoplasia; 2021 Jun; 23(6):574-583. PubMed ID: 34091121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer.
    Ohnami S; Maruyama K; Chen K; Takahashi Y; Hatakeyama K; Ohshima K; Shimoda Y; Sakai A; Kamada F; Nakatani S; Naruoka A; Ohnami S; Kusuhara M; Akiyama Y; Kagawa H; Shiomi A; Nagashima T; Urakami K; Yamaguchi K
    Mol Cell Biochem; 2021 Sep; 476(9):3469-3482. PubMed ID: 33982211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α.
    Xu A; Wang B; Fu J; Qin W; Yu T; Yang Z; Lu Q; Chen J; Chen Y; Wang H
    Cancer Lett; 2019 Feb; 442():40-52. PubMed ID: 30401637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of liver oncogenic potential among human RAS isoforms.
    Chung SI; Moon H; Ju HL; Kim DY; Cho KJ; Ribback S; Dombrowski F; Calvisi DF; Ro SW
    Oncotarget; 2016 Feb; 7(6):7354-66. PubMed ID: 26799184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.
    Okayama H; Saito M; Oue N; Weiss JM; Stauffer J; Takenoshita S; Wiltrout RH; Hussain SP; Harris CC
    Int J Cancer; 2013 Jan; 132(1):9-18. PubMed ID: 22618808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma.
    Mohamed AD; Shah N; Hettmer S; Vargesson N; Wackerhage H
    Sci Rep; 2018 Oct; 8(1):15674. PubMed ID: 30353028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis.
    Llorente Izquierdo C; Mayoral R; Flores JM; García-Palencia P; Cucarella C; Boscá L; Casado M; Martín-Sanz P
    Am J Pathol; 2011 Mar; 178(3):1361-73. PubMed ID: 21356386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
    Ako S; Nouso K; Kinugasa H; Dohi C; Matushita H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H; Okada H
    Pancreatology; 2017; 17(2):285-290. PubMed ID: 28139399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
    Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
    J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch-Sox9 Axis Mediates Hepatocyte Dedifferentiation in
    Sun J; Chen Q; Ma J
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells.
    Leiser D; Medová M; Mikami K; Nisa L; Stroka D; Blaukat A; Bladt F; Aebersold DM; Zimmer Y
    Mol Oncol; 2015 Aug; 9(7):1434-46. PubMed ID: 25933688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras.
    Podsypanina K; Politi K; Beverly LJ; Varmus HE
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5242-7. PubMed ID: 18356293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique dependence on Sos1 in
    You X; Kong G; Ranheim EA; Yang D; Zhou Y; Zhang J
    Blood; 2018 Dec; 132(24):2575-2579. PubMed ID: 30377195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models.
    Schreiber J; Grimbergen LA; Overwater I; Vaart TV; Stedehouder J; Schuhmacher AJ; Guerra C; Kushner SA; Jaarsma D; Elgersma Y
    Sci Rep; 2017 Apr; 7(1):1256. PubMed ID: 28455524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
    To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
    Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice.
    Olivera-Salazar R; García-Arranz M; Sánchez A; Olmedillas-López S; Vega-Clemente L; Serrano LJ; Herrera B; García-Olmo D
    Sci Rep; 2022 Feb; 12(1):3149. PubMed ID: 35210455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
    Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
    Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.